HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
5-phenyl-3-thioureido-1,2,4-thiadiazole
structure in first source
Also Known As:
PG301029
Networked:
3
relevant articles (
0
outcomes,
2
trials/studies)
Bio-Agent Context: Research Results
Organic Chemicals: 133
Sulfur Compounds: 278
Thiazoles: 392
Thiadiazoles: 99
5-phenyl-3-thioureido-1,2,4-thiadiazole: 3
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Azoles: 2138
Thiazoles: 392
Thiadiazoles: 99
5-phenyl-3-thioureido-1,2,4-thiadiazole: 3
Experts
1.
He, Yan
: 3 articles (03/2006 - 04/2005)
2.
Johnson, Jennifer L H
: 3 articles (03/2006 - 04/2005)
3.
Yalkowsky, Samuel H
: 3 articles (03/2006 - 04/2005)
4.
Jain, Akash
: 2 articles (03/2006 - 02/2006)
Related Diseases
1.
Hepatitis C
03/01/2006 - "
The purpose of this study was to develop and evaluate a solid nonaqueous oral dosage form for a new hepatitis C drug, PG301029, which is insoluble and unstable in water.
"
02/24/2006 - "
The purpose of this study was to develop and evaluate a solid nonaqueous oral dosage form for a new hepatitis C drug, PG301029, which is insoluble and unstable in water.
"
2.
Infections
04/08/2005 - "
To develop an oral formulation for PG301029, a novel potent agent for the treatment of Hepatitis C virus infection, that not only has very low aqueous solubility but also degrades rapidly in water.
"
Related Drugs and Biologics
1.
Dosage Forms (Dosage Form)